Abstract
Medullary thyroid cancer (MTC), accounts for approximately 5% to 10% of all thyroid cancers. Significant advances in the understanding of the biology and clinical outcomes of MTC have been made over the last decade, culminating most recently in the publication of treatment guidelines by the American Thyroid Association that follow an evidence-based approach that is summarized in this presentation. Prognosis, genetic testing, surgical technique, and re-operation are also discussed.
Original language | English (US) |
---|---|
Pages (from-to) | 365-374 |
Number of pages | 10 |
Journal | Otolaryngologic Clinics of North America |
Volume | 43 |
Issue number | 2 |
DOIs | |
State | Published - Apr 2010 |
Keywords
- DNA testing
- Evidence-based treatment
- Medullary thyroid cancer
- Prognosis
- Surgical techniques
- Thyroidectomy
- Treatment guidelines
ASJC Scopus subject areas
- Otorhinolaryngology